MGA, a program dedicated to medtech start-ups and entrepreneurs

The Medtech Generator & Accelerator (MGA) program aims to support medtech start-ups in the fields of neuroscience and genetic diseases in their growth and development. It is offered jointly by three research institutes in the Paris region, Institut du Cerveau, Institut Imagine, and Institut de la Vision.


Logos MGA

All details, objectives and offers of the MGA program are available on the dedicated website

Supporting entrepreneurs

Focused on the use of medical technologies (Medtech) for neurological and genetic/rare diseases, the program deploys tools ranging from initial training to accelerated clinical proof of concept.

The MGA program is organized around 5 action pillars to accelerate the creation of new startups and their development. Each pillar addresses the different needs of entrepreneurs and startups according to their maturity and immediate needs.

Entrepreneurship training

Flash program (Brain to Market Summer School), long immersive training (Bioentrepreneurs Launchpad), entrepreneurial team building matchmaking (Team-up for startup). An e-learning platform is also available.

Access to European funding and markets

Developing the capacity of entrepreneurs to obtain European funding and training in the specificities of European markets

UX/UI coaching

Iterative cycles of participative innovation are organized in hospitals and with the support of prototyping structures, to guarantee the final acceptability of solutions.

Clinical and regulatory strategy 

From the beginning of the project until its passage into clinical trials, various supports will be offered to optimize the choice of therapeutic indications, understand the clinical workflow and identify upstream regulatory barriers.

Removal of technological barriers 

Entrepreneurs are guided towards the industrialization process of their products, respecting the demanding framework of the medical technology field.

A joint program for comprehensive and accelerated support

The MGA program relies on a network of experimental platforms and brings together the support forces of the three university hospital institutes to offer startups and entrepreneurs privileged access to more than 1,800 scientific and medical experts, 60 dedicated technological platforms, and a vast network of alumni.

The MGA program is coordinated by the Institut du Cerveau and operated by its incubator iPEPS - The Healthtech Hub. This incubator supports some thirty startups developing solutions in the field of neuroscience and digital health at three sites.

The Institut du Cerveau, the Institut Imagine and the Institut de la Vision are international application research centers. They have been awarded the Carnot Institute label because of their expertise in industrial collaboration and project maturation.